Archives

Perfusfind S.L.

PRINCETON, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via..

Perfusfind S.L.

Abstract Background The management of hemostasis in patients medicated with apixaban (Eliquis) undergoing emergency cardiac surgery is exceedingly difficult. The body’s natural elimination pathways for apixaban prove ineffective in emergency..

Perfusfind S.L.

CytoSorb® Therapy extracorporeal blood purification is used: • in conditions where excessive levels of cytokines, bilirubin and/or myoglobin exist. • intraoperatively during cardio-pulmonary bypass (CPB) surgery for the removal of..

Perfusfind S.L.

Abstract A dysregulated host response is a common feature in critically ill patients due to both infectious and non-infectious origins that can lead to life-threatening organ dysfunction, which is still..

Perfusfind S.L.

This case reports on an 53-year-old female patient who was admitted to the hospital with an 8 day history of fever and chills, loose stools, vomiting, severe weakness, and reduced..

Perfusfind S.L.

This case reports on a 41-years old male with no significant medical history who was admitted to the emergency room following 25% total body surface area (TBSA) deep partial thickness..

Perfusfind S.L.

This case reports on a 29-year-old male, who was transferred from a peripheral hospital with a diagnosis of COVID-19-associated lower respiratory tract infection, septic shock, and multiple organ dysfunction syndrome..

Perfusfind S.L.

Abstract Introduction: Critically ill patients with inflammatory dysregulation and organ disfunction may benefit from blood purification, although the use of this technique has not been described in large case series. We..

Perfusfind S.L.

Abstract PRINCETON, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) --   (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its..

Perfusfind S.L.

Abstract Introduction Cytokine adsorption using the CytoSorb® adsorber has been proposed in various clinical settings including sepsis, ARDS, hyperinflammatory syndromes, cardiac surgery or recovery after cardiac arrest. The aim of..

Perfusfind S.L.

This case reports on a six month old male patient (weight 6 kg), who presented with agonal respiration and history of acute febrile illness. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2023/08/CoM_08_2023_E_web_compressed-1.pdf" title="CoM_08_2023_E_web_compressed"]  

Perfusfind S.L.

Abstract BACKGROUND Tricyclic antidepressant (TCA) drugs are a common cause of fatal poisoning because of their cardiotoxic and arrhythmogenic effects. Classic supportive management includes sodium bicarbonate, gastrointestinal chelating agents, and..

Perfusfind S.L.

This case reports on a 17-year-old female patient who was admitted to a regional hospital for mixed intoxication with a presumed intake of 24 g of venlafaxine (both immediate and..

Perfusfind S.L.

Abstract Background The purpose of this study was to analyze the results of Cytosorb (CytoSorbents, Monmouth Junction, NJ) adsorption during emergency open heart operations in patients at high risk of..

Perfusfind S.L.

Terapia CytoSorb en Cirugía Cardíaca de urgencia y emergencia. CytoSorb reduce las complicaciones de hemorragia en pacientes de emergencia al eliminar de modo efectivo el ticagrelor y el rivaroxaban de..

Perfusfind S.L.

Abstract Objectives: The CytoSorb therapy in COVID-19 (CTC) registry evaluated the clinical performance and treatment parameters of extracorporeal hemoadsorption integrated with veno-venous extracorporeal membrane oxygenation (VV ECMO) in critically ill COVID-19..

Perfusfind S.L.

This case reports on a 43-year-old pregnant woman, who was hospitalized for an anticipated complicated delivery. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/05/CoW_19_2021_E_web_compressed.pdf"]

Perfusfind S.L.

This case reports on a 34-year-old male patient with a history of heavy alcohol intake (1 bottle of wine per day for the past 15 years) but no other comorbidities,..

Perfusfind S.L.

This case reports on a 56-year-old female patient who was admitted to hospital by ambulance with fever (up to 42°C) that had been persisting for 4 days, lower abdominal pain..

Perfusfind S.L.

This case reports on a 60-year-old male patient who presented to hospital for elective aortocoronary bypass surgery. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2023/03/CoM_02_2023_E_web_compressed.pdf"]  

Perfusfind S.L.

This case reports on a 20-year-old patient with no relevant medical history, who was admitted to the emergency room with severe polytrauma after hitting a stationary car whilst on his..

Perfusfind S.L.

This case reports on an a 14-year-boy (43 kg) without any respiratory symptoms, who was admitted to a regional hospital with a fever of one day associated with vomiting and..

Perfusfind S.L.

This case reports on an 18-year-old male without relevant medical history, who presented at the emergency room of a peripheral primary care hospital with nausea and headaches. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2022/12/CoW_42_2022_E_web_compressed.pdf"]

Perfusfind S.L.

This case reports on an a 67-year-old woman with CHILD-C liver cirrhosis, who was admitted to the tertiary intensive care unit (ICU) after intoxication with bromazepam. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2022/12/CoW_41_2022_E_web_compressed.pdf"]  

Perfusfind S.L.

This case reports on a 68-year-old male with known arterial hypertension, who presented at the hospital by ambulance following severe deterioration of his general condition including fever up to 39°C,..

Perfusfind S.L.

This case reports on a 37-year-old male patient who was referred from a peripheral hospital with the diagnosis of Dengue fever and multiple organ failure. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2022/11/CoW_39_2022_E_web_compressed.pdf"]  

Perfusfind S.L.

This case reports on an 81-year-old man who presented to the hospital with methicillin-sensitive Staphylococcus aureus prosthetic aortic valve endocarditis and hemodynamic instability requiring an urgent operation (EuroSCORE II 31.05%)..

Perfusfind S.L.

This case reports on a 55-year-old man with hepatocellular carcinoma in the context of a hepatitis C virus (HCV)-infection since the year 2000, who was hospitalized and scheduled for an..

Perfusfind S.L.

This report describes the case of a 73-year-old male patient (known pre-existing conditions: bilateral peripheral vascular disease grade 2b, hypercholesterolemia with long-term simvastatin medication) who was admitted to the Emergency..

Perfusfind S.L.

Abstract PRINCETON, N.J., Nov. 2, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: ), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using its CytoSorb® blood purification technology,..